Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208


Role of MicroRNAs in Obesity-Induced Metabolic Disorder and Immune Response.

Zhong H, Ma M, Liang T, Guo L.

J Immunol Res. 2018 Feb 1;2018:2835761. doi: 10.1155/2018/2835761. eCollection 2018. Review.


MicroRNAs and cancer: Key paradigms in molecular therapy.

Tan W, Liu B, Qu S, Liang G, Luo W, Gong C.

Oncol Lett. 2018 Mar;15(3):2735-2742. doi: 10.3892/ol.2017.7638. Epub 2017 Dec 19.


Human Chorionic Plate-Derived Mesenchymal Stem Cells Restore Hepatic Lipid Metabolism in a Rat Model of Bile Duct Ligation.

Lee YB, Choi JH, Kim EN, Seok J, Lee HJ, Yoon JH, Kim GJ.

Stem Cells Int. 2017;2017:5180579. doi: 10.1155/2017/5180579. Epub 2017 Nov 9.


Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis.

Price NL, Rotllan N, Canfrán-Duque A, Zhang X, Pati P, Arias N, Moen J, Mayr M, Ford DA, Baldán Á, Suárez Y, Fernández-Hernando C.

Cell Rep. 2017 Oct 31;21(5):1317-1330. doi: 10.1016/j.celrep.2017.10.023.


Systems genetics identifies a co-regulated module of liver microRNAs associated with plasma LDL cholesterol in murine diet-induced dyslipidemia.

Coffey AR, Smallwood TL, Albright J, Hua K, Kanke M, Pomp D, Bennett BJ, Sethupathy P.

Physiol Genomics. 2017 Nov 1;49(11):618-629. doi: 10.1152/physiolgenomics.00050.2017. Epub 2017 Sep 15.


microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.

de Lucia C, Komici K, Borghetti G, Femminella GD, Bencivenga L, Cannavo A, Corbi G, Ferrara N, Houser SR, Koch WJ, Rengo G.

Front Med (Lausanne). 2017 Jun 12;4:74. doi: 10.3389/fmed.2017.00074. eCollection 2017. Review.


Epigenetics of Lipid Phenotypes.

Sayols-Baixeras S, Irvin MR, Arnett DK, Elosua R, Aslibekyan SW.

Curr Cardiovasc Risk Rep. 2016 Oct;10(10). pii: 31. doi: 10.1007/s12170-016-0513-6. Epub 2016 Aug 31.


microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.

Ouimet M, Ediriweera H, Afonso MS, Ramkhelawon B, Singaravelu R, Liao X, Bandler RC, Rahman K, Fisher EA, Rayner KJ, Pezacki JP, Tabas I, Moore KJ.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1058-1067. doi: 10.1161/ATVBAHA.116.308916. Epub 2017 Apr 20.


MicroRNAs and lipid metabolism.

Aryal B, Singh AK, Rotllan N, Price N, Fernández-Hernando C.

Curr Opin Lipidol. 2017 Jun;28(3):273-280. doi: 10.1097/MOL.0000000000000420. Review.


Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.

Zhang Y, Sun X, Icli B, Feinberg MW.

Endocr Rev. 2017 Apr 1;38(2):145-168. doi: 10.1210/er.2016-1122. Review.


MicroRNAs in the Pathobiology and Therapy of Atherosclerosis.

Laffont B, Rayner KJ.

Can J Cardiol. 2017 Mar;33(3):313-324. doi: 10.1016/j.cjca.2017.01.001. Epub 2017 Jan 5. Review.


MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.

Portius D, Sobolewski C, Foti M.

PPAR Res. 2017;2017:7058424. doi: 10.1155/2017/7058424. Epub 2017 Jan 12. Review.


Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis.

Liu MX, Gao M, Li CZ, Yu CZ, Yan H, Peng C, Li Y, Li CG, Ma ZL, Zhao Y, Pu MF, Miao LL, Qi XM, Ren J.

Acta Pharmacol Sin. 2017 May;38(5):660-671. doi: 10.1038/aps.2016.158. Epub 2017 Jan 23.


Diet, gonadal sex, and sex chromosome complement influence white adipose tissue miRNA expression.

Link JC, Hasin-Brumshtein Y, Cantor RM, Chen X, Arnold AP, Lusis AJ, Reue K.

BMC Genomics. 2017 Jan 17;18(1):89. doi: 10.1186/s12864-017-3484-1.


MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?

Cavarretta E, Frati G.

Biomed Res Int. 2016;2016:2150763. Epub 2016 Nov 2. Review.


Nucleic Acid Delivery for Endothelial Dysfunction in Cardiovascular Diseases.

Deshpande D, Janero DR, Segura-Ibarra V, Blanco E, Amiji MM.

Methodist Debakey Cardiovasc J. 2016 Sep;12(3):134-140. Review.


Truths and controversies concerning the role of miRNAs in atherosclerosis and lipid metabolism.

Baldán Á, Fernández-Hernando C.

Curr Opin Lipidol. 2016 Dec;27(6):623-629. Review.


The role of miRNAs in cardiovascular disease risk factors.

Jones Buie JN, Goodwin AJ, Cook JA, Halushka PV, Fan H.

Atherosclerosis. 2016 Nov;254:271-281. doi: 10.1016/j.atherosclerosis.2016.09.067. Epub 2016 Sep 22. Review.


Aberrant expression of plasma microRNA-33a in an atherosclerosis-risk group.

Kim SH, Kim GJ, Umemura T, Lee SG, Cho KJ.

Mol Biol Rep. 2017 Feb;44(1):79-88. doi: 10.1007/s11033-016-4082-z. Epub 2016 Sep 23.

Supplemental Content

Support Center